These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8480847)

  • 41. Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
    Harvey NS
    Psychosomatics; 1986 Feb; 27(2):91-3, 97-8, 102-3. PubMed ID: 3513232
    [No Abstract]   [Full Text] [Related]  

  • 42. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2002 Jun; (7):1208-20. PubMed ID: 12230738
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of anticholinergic drugs in extra-pyramidal syndromes.
    Hunter KR
    Neuropharmacology; 1981 Dec; 20(12B):1315-7. PubMed ID: 6119641
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute dystonia and fluoxetine.
    Reccoppa L; Welch WA; Ware MR
    J Clin Psychiatry; 1990 Nov; 51(11):487. PubMed ID: 2228987
    [No Abstract]   [Full Text] [Related]  

  • 46. Fluoxetine, fluvoxamine and extrapyramidal tract disorders.
    Baldwin D; Fineberg N; Montgomery S
    Int Clin Psychopharmacol; 1991; 6(1):51-8. PubMed ID: 1906498
    [No Abstract]   [Full Text] [Related]  

  • 47. [Parkinson's disease].
    Jean-Luc H
    Rev Prat; 2005 May; 55(10):1129-34. PubMed ID: 16097259
    [No Abstract]   [Full Text] [Related]  

  • 48. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2005 Jun; (13):1658-77. PubMed ID: 16135305
    [No Abstract]   [Full Text] [Related]  

  • 49. Akathisia, suicidality, and fluoxetine.
    Hamilton MS; Opler LA
    J Clin Psychiatry; 1992 Nov; 53(11):401-6. PubMed ID: 1364815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
    Beucke JC; Uhl I; Plotkin M; Winter C; Assion HJ; Endrass T; Amthauer H; Kupsch A; Juckel G
    World J Biol Psychiatry; 2010 Sep; 11(6):781-7. PubMed ID: 20586535
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serotonin and depression in frontal lobe dementia.
    Anderson IM; Scott K; Harborne G
    Am J Psychiatry; 1995 Apr; 152(4):645. PubMed ID: 7694920
    [No Abstract]   [Full Text] [Related]  

  • 52. [Parkinson's disease and neurotransmitters].
    Narabayashi H
    Nihon Rinsho; 1984 Apr; 42(4):869-74. PubMed ID: 6481982
    [No Abstract]   [Full Text] [Related]  

  • 53. Parkinson's disease, depression, and the on-off phenomenon.
    Friedenberg DL; Cummings JL
    Psychosomatics; 1989; 30(1):94-9. PubMed ID: 2913602
    [No Abstract]   [Full Text] [Related]  

  • 54. [Parkinson's disease].
    Yokochi M
    Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):5-14. PubMed ID: 10434578
    [No Abstract]   [Full Text] [Related]  

  • 55. Depression and Parkinson's disease: a review.
    Cummings JL
    Am J Psychiatry; 1992 Apr; 149(4):443-54. PubMed ID: 1372794
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
    Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Parkinson's disease.
    Lieberman A
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):339-43. PubMed ID: 8507903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.
    Prescott IA; Dostrovsky JO; Moro E; Hodaie M; Lozano AM; Hutchison WD
    Brain; 2009 Feb; 132(Pt 2):309-18. PubMed ID: 19050033
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neuropsychiatric disorders in Parkinson's disease].
    Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
    Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Molecular mechanisms of levodopa action in animal models of Parkinson's disease].
    Nowak P; Szczerbak G; Dabrowska J; Bortel A; Biedka I; Kostrzewa RM
    Neurol Neurochir Pol; 2006; 40(6):517-25. PubMed ID: 17199178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.